The genetic basis of cognition and behavioral adaptation to the environment remains poorly understood. Here we demonstrate that the histone methyltransferase complex GLP/G9a controls cognition and adaptive responses in a region-specific fashion in the adult brain. Using conditional mutagenesis in mice, we show that postnatal, neuron-specific deficiency of GLP/G9a leads to derepression of numerous nonneuronal and neuron progenitor genes in adult neurons. This transcriptional alteration is associated with complex behavioral abnormalities, including defects in learning, motivation, and environmental adaptation. The behavioral changes triggered by GLP/G9a deficiency are similar to key symptoms of the human 9q34 mental retardation syndrome that is associated with structural alterations of the GLP/EHMT1 gene. The likely causal role of GLP/G9a in mental retardation in mice and humans suggests a key role for the GLP/G9a-controlled histone H3K9 dimethylation in regulation of brain function through maintenance of the transcriptional homeostasis in adult neurons.
INTRODUCTION
A possible clue to the genetic mechanisms underlying cognition and environmental adaptation could be obtained through identification of genes responsible for mental retardation disorders. Recent studies show that many of the proteins associated with mental retardation syndromes in mice and humans are involved in epigenetic control of gene expression (Chelly et al., 2006; Inlow and Restifo, 2004; Kramer and van Bokhoven, 2009) . It has been found that altered expression of histone acetyltransferases and deacetylases as well as of proteins involved in histone or DNA methylation are associated with mental retardation syndromes (Kramer and van Bokhoven, 2009 ). These epigenetic regulators govern expression of large numbers of potentially unrelated genes. Yet, despite differences in specific functions of the distinct epigenetic regulators and their targets, impairment of chromatin function leads to symptomatically similar mental retardation syndromes (Chelly et al., 2006; Inlow and Restifo, 2004; Kramer and van Bokhoven, 2009) . Therefore, it is conceivable that mental retardation is triggered not by changes in specific target gene(s) but by the inability of neurons to respond adequately to environmental signals under conditions of greatly distorted transcriptional homeostasis (Ramocki and Zoghbi, 2008) .
Transcriptional homeostasis relies largely on the balance between positive and negative regulation of gene transcription. In mammals, di-or trimethylation of histone H3 on lysine 9 (H3K9me2 and H3K9me3) is commonly associated with gene silencing in eu-or heterochromatin, respectively (Jenuwein and Allis, 2001; Kouzarides, 2007; Zhang and Reinberg, 2001 ). The H3K9me2 is catalyzed by an enzymatic complex comprised of the histone methyltransferases G9a and G9a-like protein GLP (Ogawa et al., 2002; Peters et al., 2003; Rice et al., 2003; Shi et al., 2003; Tachibana et al., 2001; Tachibana et al., 2002 Tachibana et al., , 2005 . Genetic ablation of either of these proteins results in loss of euchromatic H3K9me2 (Peters et al., 2003; Rice et al., 2003; Sampath et al., 2007; Tachibana et al., 2001 Tachibana et al., , 2002 Tachibana et al., , 2005 . Despite the genome-wide distribution of H3K9me2, the scope and pattern of gene expression changes in the absence of this mark is rather limited and depends on the affected cell type (Kondo et al., 2008; Sampath et al., 2007; Tachibana et al., 2002; Wagschal et al., 2008) . It has been demonstrated recently that aberrant function of G9a in nonneuronal cells leads to derepression of neuronal genes outside of the nervous system (Ding et al., 2008; Roopra et al., 2004; Tahiliani et al., 2007) . This finding raises a question about the potential ability of the GLP/G9a complex to function as a master regulator of lineage-specific gene expression in the brain. In support of this model, we show that postnatal neuron-specific ablation of the histone methyltransferases GLP/ G9a leads to derepression of nonneuronal and early neuron progenitor genes in various brain areas. We also demonstrate that these changes in gene expression are associated with cognitive and behavioral defects in adult mice. The impaired brain function manifests itself either by a mental retardation-like syndrome in mice with forebrain-specific ablation of GLP/G9a or by more selective behavioral defects that follow GLP/G9a deficiency in specialized neuronal subpopulations. Collectively, our findings have revealed GLP/G9a as a key regulator of cognition, motivation, and adaptive behavior in adult mice.
RESULTS

Conditional Ablation of GLP and G9a in Postnatal Neurons Erases Euchromatic H3K9 Dimethylation
To address the role of GLP and G9a in adult brain function, we employed conditional GLP and G9a gene inactivation in postnatal mouse neurons. Gene exons encoding the SET-domain of GLP ( Figure 1A ) or G9a (Sampath et al., 2007) were flanked with loxP sites in vivo. The SET-domain is essential for the histone lysine methyltransferase activity of GLP and G9a (Tachibana et al., 2002 (Tachibana et al., , 2005 . The functional inactivation of GLP and G9a genes in postnatal neurons was accomplished by using Cre recombinase driven by the Ca 2+ /Calmodulin-dependent protein kinase II alpha gene promoter (Camk2a-Cre). This promoter is specifically active in postnatal forebrain neurons and Camk2a-Cre mice have been successfully employed for conditional modification of numerous genes in the forebrain (Casanova et al., 2001; Zhang et al., 2004 Camk2a-Cre mice, we also used Cre-expressing mice that enable conditional ablation of GLP or G9a specifically in dopamine 2 receptor (Drd2) or dopamine 1 receptor (Drd1) expressing medium spiny neurons (MSNs) in the striatum (Gong et al., 2007) . The immunohistochemical analysis of brain tissues from Camk2a-Cre; GLP fl/fl mice showed GLP deficiency in neurons of the cortex, hippocampus, striatum, and hypothalamus (Figure 1B) . Postnatal, forebrain-specific deficiency of GLP led to drastic reduction in neuronal euchromatic H3K9me2 levels ( Figures 1C and S1 ). Similar changes in euchromatic H3K9me2 levels occurred in neurons of Camk2a-Cre mice homozygous for the mutant G9a allele (Camk2a-Cre; G9a fl/fl ) ( Figure 1C ), confirming the previously reported essential role of the GLP/G9a complex in euchromatic H3K9me2 (Peters et al., 2003; Rice et al., 2003; Sampath et al., 2007; Tachibana et al., 2002 Tachibana et al., , 2005 . Similarly, the Cre-mediated alteration of G9a specifically in Drd1-or Drd2-expressing neurons in the striatum resulted in loss of euchromatic H3K9me2 ( Figure S1 ). As previously shown for G9a-deficient ES cells and fibroblasts (Peters et al., 2003; Sampath et al., 2007) , the GLP/G9a-deficient neurons still show heterochromatic H3K9me2 ( Figures 1C, S1 , and S2), which may derive from enzymatic demethylation of heterochromatic H3K9me3. In agreement with the previously reported selective role of GLP/G9a in formation of euchromatic H3K9me2 in cells of various types (Peters et al., 2003; Rice et al., 2003; Sampath et al., 2007; Tachibana et al., 2002 Tachibana et al., , 2005 , the postnatal, neuron-specific deficiency of GLP and G9a had no impact on neuronal heterochromatic H3K9me3 ( Figure S2 ).
GLP/G9a Control Expression of Lineage-Specific Genes in Adult Neurons
Conditional inactivation of GLP or G9a in striatum, hippocampus, hypothalamus, or cortex led to upregulation of a large number of genes ( Figure 2A , Tables S1-S9) . Comparison of gene expression within the functionally distinct, GLP-or G9a-deficient brain regions, as well as the cross-area comparison, revealed about 60 genes that collectively comprise a genetic ''signature'' of GLP or G9a deficiency in the adult forebrain ( Figures 2B-2D ). In addition to the commonly expressed genes, each of the individual G9a-or GLP-deficient brain areas shows upregulation of additional neuronal genes depending on the specific brain region (Tables S2-S9) . Combined GLP and G9a deficiencies (Camk2a-Cre; GLP fl/fl ; G9a fl/fl ) had no additional impact on gene expression changes as compared to mice with a single methyltransferase deficiency (data not shown). The vast majority of the ''signature'' genes encode for proteins that are normally not expressed in adult neurons (Figures 2C and 2D) . A significant fraction of these genes is involved in development and function of the skeletal, muscular, cardiovascular, hematological, and immune systems ( Figures 2C and 2D ). The degree of GLP and G9a impact on repression of nonneuronal genes is highlighted by neuronal expression of Afamin (Afm) or a-fetoprotein (Afp) in the striatum and cortex of GPL-or G9a-deficient mice (Tables S1, S4 , S5, S8, and S9). Afamin and a-fetoprotein belong to the family of serum albumins and are highly expressed in the embryonic liver but are transcriptionally silenced in mature neurons (Lichenstein et al., 1994; Nguyen et al., 2005) . In addition to suppression of genes of nonneuronal lineage, GLP and G9a appear to control development-stagedependent neuronal gene expression. In particular, deficiency in GLP or G9a in adult neurons reactivates expression of the transcriptional regulator Dach2 (Tables S1-S11), which is expressed during embryonic brain, eye, and limb development (Davis et al., 2001) . Upregulation of Dach2 is particularly interesting in view of the human DACH2 gene localization on the X chromosome in a region that is affected in a number of human mental retardation syndromes (Davis et al., 2001) . The neuron-specificity of the observed gene expression changes was validated by using the bacTRAP approach (Doyle et al., 2008; Heiman et al., 2008) Afp, Anxa10, Bank1, Ces7, Corin, Dach2, Defb1, Expi, Gbe1, Gkn1, Lama2, Lamb3, Musk, Myh1, Nxf3, Olfm4, Serpinb1b, Serpinb5, Ttn, and Tnnt2 (Tables S1, S10 , and S11). This result indicates that the derepression of nonneuronal genes in GLP-or G9a-deficient postnatal neurons is likely to be neuron intrinsic.
Unaltered Neuronal Architecture in the Absence of GLP or G9a
Deficiency in GLP or G9a and ensuing changes in gene expression had no apparent impact on the structural organization of the affected brain areas ( Figure 3A) . Moreover, the specific neuronal cell architecture in the striatum and the hippocampus was not altered by forebrain-specific postnatal GLP or G9a deficiency ( Figures 3B-3E) . Similarly, the lack of GLP/G9a had no major impact on regulation of neuronal morphology and basal electrophysiological features of Drd2-expressing MSNs in the striatum of Drd2-Cre; G9a fl/fl mice ( Figure 4) . Preservation of neuronal cell survival, morphology, and cell-type-specific electrophysiological features in GLP-or G9a-deficient neurons rules out an essential role of GLP/G9a and H3K9me2 in regulation of vital cellular processes. Similar conclusions have been achieved by studies that evaluated the impact of G9a deficiency on fibroblasts, peripheral lymphocytes, and cardiomyocytes (Sampath et al., 2007; Shirato et al., 2009; Thomas et al., 2008) .
Deficiency in GLP/G9a Leads to Complex Behavioral Abnormalities and Cognitive Impairment in Adult Mice
In humans, genetic alterations of the GLP gene are associated with a severe mental retardation syndrome that is further characterized by craniofacial abnormalities, hypotonia, obesity, and a gradual decline in goal-directed cognition and behavior, including a loss of interest in the environment, reduced motor activity, and emotional responsiveness (Cormier-Daire et al., 2003; Kleefstra et al., 2006 Kleefstra et al., , 2009 Kramer and van Bokhoven, 2009; Verhoeven et al., 2009) . Mental retardation in humans is defined by impaired cognitive function and deficits in adaptive Figures 5C and 5D ), confirming the essential role of a functional GLP/G9a complex in regulation of motor activity and explorative behavior. Importantly, none of the observed behavioral aberrations is found in mice with a Camk2a-Cre-mediated ablation of the histone lysine methyltransferase Ezh2 (CamK2a-Cre; Ezh2 fl/fl mice) ( Figures 5C and 5D ), which is essential for H3K27 methylation (Cao et al., 2002; Su et al., 2003) and has been shown to play an important role in lineagespecific gene expression and differentiation of various types of cells including neurons and astrocytes (Bracken et al., 2006; Cao and Zhang, 2004; Hirabayashi et al., 2009 ). Abnormal exploratory behavior in the absence of GLP/G9a could conceivably reflect a defect in motor function or balance. However, the Camk2a-Cre; GLP fl/fl mice did not display any reduction in motor activity or balance during the standard accelerated rotarod analysis. In fact, the mutant mice seemed to perform even slightly better than their littermate controls ( Figure 6A ). Likewise, the elevated plus maze analysis, a test used to diagnose anxiety-like behavior in rodents, did not reveal any anxiety-like phenotype that could explain the observed reduction in exploratory behavior ( Figure 6B Figure 6B ). GLP/G9a-deficient mice also showed a significant decrease in total arm entries ( Figure 6B ), which is consistent with the previously described reduction in explorative behavior in the open field ( Figure 4 ). The reduction in locomotion and exploration in postnatal, neuron-specific GLP/G9a-deficient mice could as well represent a general loss of curiosity and interest in the environment, implying potential deficits in the motivation or reward mechanism. To address the ability of these mice to seek/respond to rewards independently from their impaired locomotor activity and exploration, GLP/G9a-deficient mice were tested for their preference for sucrose, a sweet-tasting natural reward. Wildtype mice, when given a choice to drink regular water versus 1% sucrose, clearly prefer sucrose. Mice with a postnatal, neuron-specific deficiency in GLP or G9a almost completely lacked the preference for sucrose ( Figure 6C ). Decreased sucrose preference may indicate an underlying dysfunction in the motivation/reward mechanism in these mice. Contextual and cued fear conditioning is a behavioral test that evaluates the ability of mice to learn and remember associations between environmental cues and an aversive experience. The mice learn to associate a neutral context (test chamber) and a neutral stimulus (audio cue) with an aversive stimulus (mild foot shock). Learned association of the previous neutral cues with the aversive stimulus leads to the exhibition of a freezing response, which is characterized by an immobile and tense posture. Analysis of the Camk2a-Cre; GLP fl/fl mice using the standard fear conditioning paradigm demonstrated that while initial pain sensitivity and freezing in response to mild foot shock were not affected by GLP deficiency, the mutant mice did not remember their negative experience ( Figure 6D ). The freezing response to the contextual conditioned fear, as well as to the audio cued conditioned fear was significantly impaired in the GLP mutant mice as compared to their littermate controls ( Figure 6D) . Thus, the deficiency of GLP in postnatal neurons causes severe defects in learning and memory. Many of the mental retardation syndromes in humans and mice are frequently associated with the development of obesity (Cormier-Daire et al., 2003; Fyffe et al., 2008; Goldstone and Beales, 2008) . The same is true for the Camk2a-Cre; GLP fl/fl and the Camk2a-Cre; G9a fl/fl mice, which became obese and almost doubled their body weight as compared to their controls by 5-6 months of age ( Figure S3 ). Importantly, the described increase in body weight appears several weeks after the manifestation of reduced locomotion and exploration in these mice and therefore could be a consequence of, but not a reason for, the behavioral abnormalities described above ( Figure S3 ). Figures 7A, 7C , and 7E). On the other hand, decreased activity of Drd2 neurons is achieved either by inhibiting the adenosine-2-a (A2a) receptor or by activating the Drd2 receptor. Injection of caffeine, an A2a-receptor antagonist, which specifically reduces the activity of Drd2 MSNs, induced an increase in locomotor and exploratory activity in wild-type mice. Drd2 cell-specific deletion of G9a led to a hyper-responsiveness to caffeine, which was marked by a significantly higher increase in locomotor and exploratory response upon Drd2 MSN inhibition in vivo ( Figures 7B, 7D , and 7F). In summary, deficiency of 
Deficiency of GLP/G9a in
Neuron Epigenetic Control of Behavior and Cognition
GLP/G9a in either of the two distinct neuronal populations in the striatum is associated with an alteration of the responsiveness of these cells to specific stimuli/inhibitors in vivo and reveals a significant reduction of cell-type-specific activity in both neuronal populations. These data demonstrate neuron/brainregion-specific functions of GLP/G9a in regulation of specific behavioral responses.
DISCUSSION
We have identified GLP/G9a as key regulators of cognition and adaptive behavior in adult mice. The mechanism of GLP/G9a involvement in brain function is likely to reflect the ability of these enzymes to maintain neuron-specific transcriptional homeostasis and to protect adult neurons from expression of numerous nonneuronal and neuronal progenitor genes. It is conceivable that ectopic expression of regulatory proteins that are involved in calcium and cAMP signaling (Bank1, Annexin-10, ArhGAP15, CaBP5, MuSK, Plce1) and cytoskeletal function (myosin-1, myosin-7, myomesin-2, titin, Tnnt2) may interfere significantly with the function of the tightly regulated intracellular signaling networks. Additionally, proteins of the laminin family like Lama2, Lama3, and Lamb3 that become upregulated in the absence of GLP/G9a are known to control cell-to-cell communication (Sché ele et al., 2007) and may, therefore, interfere with neuronal connectivity in the brain. Finally, several of the upregulated ''signature'' proteins including a-fetoprotein, afamin, carboxylesterase 7, b-defensin 1, gastrokine-1, olfactomedin-4, serpin B1b, and serpin B5 have been described as potent secreted regulators of various cell functions (Bailey et al., 2006; Benarafa et al., 2002; Holmes et al., 2008; Jensen et al., 2009; Niyonsaba et al., 2005; Oien et al., 2004) . Production of these proteins by neurons could induce secondary changes in neighboring neurons or nonneuronal cells. Overall, it is likely that multiple gene defects rather than a single gene alteration are responsible for the complex behavioral changes in the absence of GLP/G9a. Our data show that deficiency in GLP/G9a and ensuing changes in gene expression have a differential impact on specialized brain areas. Inactivation of GLP/G9a in large numbers of functionally diverse neurons in the postnatal forebrain leads to a mental-retardation-like phenotype in adult mice. Contrary to forebrain-specific GLP/G9a deficiency in the Camk2a-Cre mice, ablation of these enzymes in highly specialized Drd1 or Drd2 neurons in the striatum causes behavioral changes only after pharmacological perturbation of Drd1 or Drd2 cell function. It is conceivable that the observed differences in the severity of the basal behavioral phenotypes are simply proportional to the size and functional diversity of the affected neuronal populations. Accordingly, the potential impact of GLP/G9a deficiency in specialized brain areas or neuronal subpopulations, such as Drd1-or Drd2-expressing MSNs, could be revealed only after perturbation of these neurons.
Comparison of the complex behavioral abnormalities in mice with conditional postnatal GLP/G9a deficiency revealed a strong resemblance to the human mental retardation syndrome associated with the subtelomeric deletion of the human chromosome 9 (9q34), which includes the histone lysine methyltransferase GLP/EHMT1 gene. In addition to major defects in cognition and learning, the 9q34 syndrome is further characterized by obesity, childhood hypotonia, and a gradual, age-dependent development of severe apathetic behavior, reduced motor activity, and loss of goal-directed activities (Cormier-Daire et al., 2003; Kleefstra et al., 2006 Kleefstra et al., , 2009 Kramer and van Bokhoven, 2009; Verhoeven et al., 2009 ). The potential causal role of the GLP/EHMT1 gene alterations (OMIM 607001) in the human 9q34 mental retardation syndrome has been underscored by the identification of various intragenic GLP/EHMT1 mutations in patients with a mental retardation syndrome clinically indistinguishable from 9q34 deletion syndrome Kramer and van Bokhoven, 2009 ). Five of the identified mutations in the GLP/EHMT1 gene predict a premature termination codon resulting in nonsense-mediated mRNA decay, whereas one of the mutations leads to an amino acid substitution that is predicted to affect the conformation and hence the activity of the highly conserved, histone methyltransferase encoding SET-domain of the GLP/EHMT1 protein .
The presence of key symptoms of the human 9q34 mental retardation syndrome in mice with a postnatal, neuron-specific GLP/G9a deficiency supports a causal role of GLP/G9a in impaired neuron-specific function in the human disease. In humans, deficiency in GLP is likely to affect both the development and the function of the adult neurons. Our findings suggest that deficiency in GLP/G9a in the postnatal mouse brain is sufficient to cause complex behavioral changes. The latter finding indicates a possible role of GLP/G9a regulation of adult brain function, including cognition, in normal individuals. It has been demonstrated recently that the protein level and histone methyltransferase activity of G9a can be regulated by oxygen concentration (Chen et al., 2006) . Therefore, it is possible that changes in local oxygen concentrations in the brain may affect changes in brain function due to alteration of GLP/G9a-mediated gene regulation. Thus, it seems plausible that genetically predetermined or environmentally induced changes of enzymes controlling H3K9me2 methylation may determine individual differences in cognition and environmental adaptation in mice and humans.
EXPERIMENTAL PROCEDURES Cloning of Targeting Construct and Generation of GLP fl/fl Mice
To create the GLP targeting vector, a region of the GLP genomic locus containing the long and short arms of homology was recombinogenically subcloned from a BAC clone (RPCI24-156K12; BL/6; CHORI, Oakland CA, USA) into pBlueScriptIIKS+ essentially as described (Lee et al., 2001; Sampath et al., 2007; Yu et al., 2000) , using primers which inserted a 5 0 AscI site and a 3 0 FseI site. The properly recombined plasmid was digested with NheI, and an annealed double-stranded oligonucleotide containing the upstream loxP site and a BsrGI site was inserted. The vector was then digested with BamHI, and a NsiI fragment from pZeroloxP-FRT-neo R -FRT(-) containing the downstream loxP site and FRT-flanked neo gene was inserted and screened for proper orientation. The resulting plasmid was digested with AscI and FseI to release the targeted locus, which was inserted into XhoI-digested pDTA-TK to produce the final targeting construct. Induced deletion of exon 23 is predicted to lead to out-of-frame splicing and Nonsense-Mediated Decay of the transcript. E14.1 (129/Ola) embryonic stem cells were transfected, selected, and used to produce chimeric mice as described (Torres and Kuhn, 1997) . Chimeras were crossed to C57/BL6 and germline transmission was assessed by coat color, PCR and Southern blot analysis (GLP-probe-B: CCTGTTAAACAT GGCTGCTTG). Deletion of the FRT-flanked neo gene was accomplished by crossing of mice carrying the GLP Targ allele in the germline to FLPe-transgenic mice (Rodríguez et al., 2000) . Routine genotyping was performed by tail biopsy and PCR using following primers: GLP-type-1: GGGTTGTGCTCAGAGTTTC TACCTC, GLP-type-2: TCCCTCATCGCCCACAT TTCTG, GLP-type-3: CCGG AGATGAGGAAGAGGAGAACAG.
Generation of Neuron-Specific GLP, G9a, and Ezh2 Mutant Mice GLP fl/fl , G9a fl/fl (Sampath et al., 2007) and Ezh2 fl/fl (Su et al., 2003) were bred to Camk2a-Cre (Casanova et al., 2001) with mice that express Cre-recombinase under the control of the ubiquitously expressed CMV promotor (CMV-Cre mice, Jackson Laboratory). Drd2-bac-TRAP and Drd2-eGFP (Heintz, 2004) mate controls were anesthetized with pentobarbitol and transcardially perfused with 10 ml of phosphate-buffered saline (PBS) followed by 40 ml of 4% paraformaldehyde (PFA) in PBS. Brains were processed as previously described (Schaefer et al., 2007) . For GLP immunohistochemistry, sections underwent antigen retrieval by heating in citrate solution (pH = 6.0), were incubated with anti-GLP antibody (1:1000, R&D Systems, Minneapolis, MN) and visualized by the avidin-biotin-peroxidase complex method (Vector Laboratories, Burlingame, CA) as recommended by the manufacturer. DAB enhanced liquid substrate system (Sigma-Aldrich) was used to detect peroxidase activity, and sections were mounted using Crystal Mount solution (Biomedia, Foster City, CA). GFP (1:5000, ab6556), H3K9me2 (1:500, ab1220), and H3K9me3 (1:1000, ab8898, all Abcam, Cambridge, MA) were visualized using indirect immunofluorescence analysis (Alexa Fluor 546/488 labeled goat anti-mouse/anti-rabbit IgGs (H + L) dilution 1:500, Invitrogen Corporation, Carlsbad, CA). Draq5 (Biostatus Limited, Leicestershire, UK) was used to counterstain the nucleus and sections were mounted using Prolong Gold antifade (Invitrogen Corporation, Carlsbad, CA). The brains were rapidly removed, glued to the stage of a VT1000S slicer (Leica, Nussloch, Germany), and immersed in ice-cold aCSF. Striatal slices were cut at a thickness of 240 mm and transferred to a holding chamber, where they were submerged in aCSF, incubated at 35 C for 30 min, and returned to room temperature before recording. Recordings were made at room temperature (20 C-22 C) with patch electrodes fabricated from filamented, thick-wall borosilicate-glass (Sutter Instruments, Novato, CA) pulled on a Flaming-Brown puller (P-97; Sutter). Pipette resistance was typically $3-5 MU when filled with internal solution consisting of (in mM) 135 KMeSO 4 , 5 KCl, 10 Na-phosphocreatine, 5.0 EGTA, 0.5 CaCl 2 , 2.0 Mg-ATP, 0.5 Na 3 -GTP, 5 HEPES, 0.2% w/v biocytin, pH 7.25-7.30, 300 mOsm. The liquid junction potential in recordings was $7 mV and not corrected for. MSNs within the dorsal striatum were identified by their somatic morphological characteristics under IR-DIC optics. Somatic eGFP expression was verified routinely in cell-attach mode using epifluorescence microscopy to confirm cell identity before breaking into wholecell mode. Somatic whole-cell patch-clamp recordings were obtained with a MultiClamp 700B amplifier (Molecular Devices, Union City, CA) interfaced to a Pentium-based PC running pClamp9 (Molecular Devices). For currentclamp recordings, the amplifier bridge circuit was adjusted to compensate for electrode resistance and subsequently monitored. For anatomical reconstruction, slices in which eGFP positive Drd2 cells were recorded in wholecell mode for at least 30 min were flat-mounted on nitrocellulose filters (Millipore; Billerica, MA), fixed in 4% paraformaldehye for 72 hr, and reacted with 2 mg/ml streptavidin-Alexa Fluor 594 (Invitrogen; Carlsbad, CA) in 2% Triton-X, 1% NGS prepared in PBS overnight. Sections were then washed, coverslipped, and imaged as detailed previously (Gertler et al., 2008) . 19C8, 19F7) for the immunoprecipitation reaction (Doyle et al., 2008; Heiman et al., 2008) .
Brain Morphology Analysis
RNA Preparation
Gene Expression Analysis
Purified mRNA or total RNA was amplified and processed for using the Affymetrix two cycle cDNA Synthesis kit (Affymetrix, Santa Clara, CA) as previously described (Doyle et al., 2008; Heiman et al., 2008) . Affymetrix Mouse Genome 430 2.0 arrays were used in all experiments. Information regarding the array design and features can be found at www. affymetrix.com. Mouse Genome 430 2.0 arrays were scanned using the GeneChip Scanner 3000 (Affymetrix, Santa Clara, CA) and globally scaled to 150 using the Affymetrix GeneChip Operating Software (GCOS v1.4). Three/four biological replicates were performed for each experiment. GeneChip CEL files were imported together into Genespring GX 7.3.1 (Agilent Technologies, Santa Clara, CA), processed with the GC-RMA algorithm, and expression values on each chip were normalized to that chip's 50th percentile. Statistical analysis was carried out to determine which genes are differentially expressed in the GLP-and G9a-deficient cortex, striatum, hippocampus, and hypothalamus as compared to their respective controls, and G9a-deficient Drd1 and Drd2 MSNs as compared to their respective controls. The minimum information about a microarray experiment (MIAMI) compliant summary of the gene expression analysis can be found in the Supplemental Experimental Procedures section. Activity in the open-field was quantified by a computer-operated Photobeam activity system (AccuScan Instruments, Columbus, OH). Mice were recorded for the total distance moved (cm), number of vertical episodes (rearing), and distance moved in the center of the arena (cm). The distance moved in the center (cm) was divided by the total distance moved (cm) to obtain center/total distance ratio values. Data were collected at 5-10 min intervals over 20-60 min test sessions. Saline, Drd1-agonist SKF 81297 (5 mg/kg in saline, Tocris, Ellisville, MO) and caffeine (10 mg/kg in saline, Sigma, St. Louis, MO) have been used for intraperitoneal injections.
Behavioral Analysis
Rotarod Analysis
The motor function and balance of mice was analyzed using the standard accelerated rotarod test (4-40 rpm/5 min, Med Associates, St. Albans, VT). The time taken for the mice to fall from the rod was measured in seconds. If a mouse, clinging on to the rod, completed two full passive rotations, the mouse was removed from the trial and the time was recorded as fallen from the rod. If a mouse stayed on the rod until the end of the 5 min trial, a time of 300 s was recorded. After one training trial, mice were subjected to three consecutive trials/day with 5 min intertrial intervals for three consecutive days and measurements were taken from each trial.
Elevated Plus Maze Analysis
The elevated plus maze test was used to determine the unconditioned response to a potentially dangerous environment. Anxiety- and age matched littermate controls (n = 5/genotype) was measured as an index for motivation and reward. All animals were single housed 3-4 days prior to the beginning of the sucrose preference testing. Two 50 ml bottles fitted with two-balled sipper tubes (Ancare, Bellmore, NY) were positioned on the food rack. The experiment started with 2 days of water in both bottles, followed by 2 days with 1% sucrose in both bottles, and 4 days of a water-sucrose choice. The fluid levels in both bottles were measured every evening at 6 PM, and the bottle position was switched daily to avoid side biases. The total amount of sucrose was divided by the total amount of water consumed during the 4 days of water-sucrose choice to calculate the sucrose/water preference ratio.
Fear Conditioning Analysis
Memory and learning abilities of Camk2a-Cre; GLP fl/fl and their sex and age matched littermate controls (n = 13/genotype) have been analyzed using a standard fear conditioning paradigm (Med Associates, St. Albans, VT). The test chamber (neutral context) was made of clear Plexiglas. The bottom of the test chamber was a grid floor used to deliver a mild electric foot shock. The test chamber was placed inside a sound-attenuated chamber. Mice were observed through a window in the front of the sound-attenuated chamber. One mouse was placed in the test chamber (house lights on) and allowed to explore freely for 2 min. A white noise (80 dB), which served as the conditioned stimulus, was then presented for 30 s, followed by a mild (2 s, 0.5 mA) foot shock, which served as the unconditioned stimulus. Two minutes later the same sequence of auditory cue-shock pairing was repeated. The mouse was removed from the chamber 30 s later and returned to its home cage. Freezing behavior was recorded every 10 s during the time spend in the test chamber. Responses (run, jump, and vocalize) to the foot shock were also recorded. Twenty-four hours later, the mouse was placed back into the test chamber for 5 min, and the presence of freezing behavior was recorded (context test). Two hours later, the mouse was tested for its freezing respond to the auditory cue. Environmental and contextual cues were changed for the auditory cue test: a black Plexiglas triangular insert was placed in the chamber to alter its shape, spatial cues, and lightening; the wire grid floor was covered with white Plexiglas; and orange extract was placed in the chamber to alter the smell. The auditory cue test was divided into two phases. During the first phase, freezing behavior was recorded for 3 min in the absence of the auditory cue. In the second phase, the auditory cue was turned on, and freezing was recorded for another 3 min. 
